Skip to main content
Premium Trial:

Request an Annual Quote

BioDiscovery, Genops Ink Plan to Integrate IT Platforms

NEW YORK, Feb. 27 - BioDiscovery and Genops Bioinformatics have announced plans to integrate their platform products.


The companies say the plan is to integrate BioDiscovery's GeneDirector with Genops' Ngene software and Linux cluster platform for high-throughput sequence analysis and annotation.

The firms explain that the goal of their agreement is "to provide a seamless product for integrated gene expression analysis." Both Ngene and GeneDirector have been designed as "expandable platforms" that can handle genomic- and proteomic-data integration.


Financial terms of the agreement were not disclosed.


"Our partnership aims to provide a cohesive data, experiment, and knowledge management core with the ability to ... analyze, compare, and annotate information generated from array experiments.... ," Soheil Shams, BioDiscovery's CEO, said in a statement.


This is not the first deal of its kind for Genops. Last September, the Vancouver, British Columbia-based company and bioinformatics startup Zerosum penned an information-sharing partnership designed to help Genops broaden its Ngene software while at the same time boost Zerosum's burgeoning business.


The deal also will help Zerosum, of Seven Valleys, Penn., expand its Bioinformatics Infrastructure Operations Center's life-science computing services.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.